New surgery combo for pancreatic cancer aims to cut complications and speed recovery
NCT ID NCT05843877
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two surgical approaches for people with pancreatic cancer who are at high risk for a serious complication called a pancreatic fistula. One group gets the standard surgery that removes only the tumor-affected part of the pancreas. The other group has the entire pancreas removed and receives a transplant of their own insulin-making cells (islets) into the liver. The goal is to see if the more extensive surgery reduces complications and helps patients start additional cancer treatments faster.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous pancreatic islet cells
- What this could lead to
- If successful, this approach could reduce serious complications after pancreatic cancer surgery and help patients start additional cancer treatments sooner.
- What could go wrong
- This is a small early-phase trial with only 32 participants, so results may not apply to all patients. The islet transplant may not produce enough insulin, and patients will still need close monitoring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIAMPULLARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Carl Gustav Carus Technische Universität Dresden
RECRUITINGDresden, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery
- Gut bacteria may forecast surgery risks in pancreatic cancer patients
- Mood drug trial for pancreatic cancer patients halted early
- Simple blood test could spot infections faster after pancreatic surgery
- Glue injection could seal pancreas after cancer surgery
- New ultrasound test may predict dangerous pancreatic leaks after surgery